The lysosomal function of progranulin, a guardian against neurodegeneration Daniel H. PaushterHuan DuFenghua Hu Review 09 May 2018 Pages: 1 - 17
Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain Wei HongZemin WangDominic M. Walsh Original Paper 23 April 2018 Pages: 19 - 40
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers Maitrayee Sardar SinhaAnna Ansell-SchultzMartin Hallbeck Original Paper Open access 13 June 2018 Pages: 41 - 56
Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART Sarah K. KaufmanKelly Del TrediciMarc I. Diamond Original Paper Open access 11 May 2018 Pages: 57 - 67
Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders Brian SpencerSven BrüschweilerEliezer Masliah Original Paper 14 June 2018 Pages: 69 - 87
Aging alters the immunological response to ischemic stroke Rodney M. RitzelYun-Ju LaiLouise D. McCullough Original Paper Open access 11 May 2018 Pages: 89 - 110
CADASIL brain vessels show a HTRA1 loss-of-function profile Andreas ZellnerEva ScharrerChristof Haffner Original Paper 03 May 2018 Pages: 111 - 125
Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls, while the neuropil is not affected: an autopsy study Stefanie FingerhutMichael SperlingUwe Karst Original Paper 10 May 2018 Pages: 127 - 138
Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways Nazira J. AlbargothyDavid A. JohnstonRoxana O. Carare Original Paper Open access 12 May 2018 Pages: 139 - 152
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas Mitsuaki ShirahataTakahiro OnoAndreas von Deimling Original Paper 23 April 2018 Pages: 153 - 166
Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation Payal JainLea F. SurreyAngela J. Waanders Correspondence Open access 16 May 2018 Pages: 167 - 169
A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)” André O. von BuerenMichael KarremannChristof M. Kramm Correspondence 21 May 2018 Pages: 171 - 173
K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution Henning LeskeElisabeth RushingIoannis Panagopoulos Correspondence 15 May 2018 Pages: 175 - 176